Alok Singh
Concepts (509)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Urinary Bladder Neoplasms | 7 | 2024 | 228 | 2.380 |
Why?
| Mycobacterium tuberculosis | 10 | 2025 | 308 | 1.680 |
Why?
| Leishmania donovani | 4 | 2016 | 7 | 1.550 |
Why?
| Tuberculosis | 7 | 2023 | 272 | 1.340 |
Why?
| BCG Vaccine | 4 | 2022 | 24 | 1.310 |
Why?
| Carboxylic Acids | 4 | 2013 | 32 | 1.230 |
Why?
| Antitubercular Agents | 4 | 2025 | 200 | 1.180 |
Why?
| Neurocysticercosis | 2 | 2018 | 8 | 1.150 |
Why?
| Macrophages | 9 | 2023 | 1480 | 1.000 |
Why?
| Dinucleoside Phosphates | 2 | 2022 | 28 | 0.940 |
Why?
| Gastric Outlet Obstruction | 1 | 2024 | 9 | 0.920 |
Why?
| Self Expandable Metallic Stents | 1 | 2024 | 14 | 0.910 |
Why?
| Mycobacterium bovis | 2 | 2021 | 16 | 0.900 |
Why?
| Seizures | 2 | 2018 | 402 | 0.900 |
Why?
| Refuse Disposal | 1 | 2023 | 4 | 0.870 |
Why?
| Waste Management | 1 | 2023 | 10 | 0.870 |
Why?
| Gallstones | 1 | 2023 | 31 | 0.860 |
Why?
| Oxygen | 3 | 2013 | 915 | 0.830 |
Why?
| Mite Infestations | 2 | 2020 | 6 | 0.820 |
Why?
| Titanium | 3 | 2012 | 77 | 0.800 |
Why?
| Dog Diseases | 2 | 2020 | 52 | 0.790 |
Why?
| Virus Diseases | 2 | 2022 | 211 | 0.780 |
Why?
| Tuberculosis Vaccines | 1 | 2021 | 4 | 0.760 |
Why?
| Nomograms | 1 | 2022 | 47 | 0.740 |
Why?
| Myopia | 1 | 2022 | 47 | 0.740 |
Why?
| Onium Compounds | 2 | 2017 | 11 | 0.720 |
Why?
| Blood-Brain Barrier | 2 | 2021 | 132 | 0.700 |
Why?
| Subarachnoid Hemorrhage | 1 | 2021 | 64 | 0.700 |
Why?
| Ivermectin | 1 | 2020 | 13 | 0.690 |
Why?
| Cancer Vaccines | 1 | 2022 | 164 | 0.690 |
Why?
| Cytokines | 5 | 2022 | 2017 | 0.670 |
Why?
| Tuberculosis, Multidrug-Resistant | 2 | 2017 | 57 | 0.670 |
Why?
| Deglutition | 1 | 2020 | 67 | 0.670 |
Why?
| Hypogonadism | 1 | 2020 | 84 | 0.660 |
Why?
| Mites | 1 | 2019 | 6 | 0.660 |
Why?
| Cardiovascular Diseases | 7 | 2025 | 2004 | 0.650 |
Why?
| Stents | 1 | 2023 | 504 | 0.640 |
Why?
| Immunity, Cellular | 1 | 2021 | 265 | 0.640 |
Why?
| Glucose Intolerance | 1 | 2020 | 142 | 0.620 |
Why?
| Nanostructures | 3 | 2024 | 100 | 0.620 |
Why?
| Deglutition Disorders | 1 | 2020 | 133 | 0.610 |
Why?
| Pyrazoles | 2 | 2021 | 405 | 0.590 |
Why?
| Schiff Bases | 3 | 2012 | 7 | 0.590 |
Why?
| Autophagy | 2 | 2020 | 268 | 0.580 |
Why?
| Mannich Bases | 1 | 2017 | 1 | 0.580 |
Why?
| Curcumin | 1 | 2017 | 29 | 0.550 |
Why?
| Glycolipids | 1 | 2017 | 42 | 0.550 |
Why?
| Anti-Bacterial Agents | 5 | 2019 | 1717 | 0.540 |
Why?
| Image Enhancement | 1 | 2018 | 167 | 0.540 |
Why?
| Mycobacterium Infections, Nontuberculous | 2 | 2021 | 352 | 0.530 |
Why?
| Leishmaniasis, Visceral | 1 | 2016 | 7 | 0.530 |
Why?
| Positron-Emission Tomography | 4 | 2025 | 288 | 0.520 |
Why?
| Spectrophotometry, Infrared | 7 | 2013 | 54 | 0.520 |
Why?
| X-Ray Diffraction | 7 | 2013 | 94 | 0.510 |
Why?
| Drug Resistance, Multiple, Bacterial | 1 | 2016 | 71 | 0.510 |
Why?
| Animals | 34 | 2025 | 35360 | 0.500 |
Why?
| Multiple Sclerosis | 1 | 2021 | 436 | 0.490 |
Why?
| Nontuberculous Mycobacteria | 1 | 2017 | 203 | 0.490 |
Why?
| Humans | 54 | 2025 | 129622 | 0.490 |
Why?
| Pneumonia, Viral | 1 | 2020 | 341 | 0.480 |
Why?
| Coronavirus Infections | 1 | 2020 | 335 | 0.480 |
Why?
| Contrast Media | 1 | 2018 | 393 | 0.470 |
Why?
| Eflornithine | 1 | 2014 | 4 | 0.450 |
Why?
| Drug Resistance | 2 | 2014 | 166 | 0.440 |
Why?
| Host-Pathogen Interactions | 2 | 2017 | 352 | 0.440 |
Why?
| Gene Expression Profiling | 3 | 2016 | 1706 | 0.440 |
Why?
| T-Lymphocytes | 2 | 2021 | 1928 | 0.430 |
Why?
| Metabolic Diseases | 2 | 2025 | 104 | 0.420 |
Why?
| Brain | 4 | 2018 | 2679 | 0.420 |
Why?
| Iron Compounds | 1 | 2013 | 6 | 0.420 |
Why?
| Metals | 2 | 2014 | 128 | 0.420 |
Why?
| Insulin Resistance | 2 | 2024 | 1165 | 0.410 |
Why?
| Lipid Metabolism | 1 | 2016 | 497 | 0.410 |
Why?
| Proteome | 2 | 2015 | 443 | 0.410 |
Why?
| Organometallic Compounds | 2 | 2014 | 107 | 0.400 |
Why?
| Coordination Complexes | 1 | 2012 | 13 | 0.400 |
Why?
| Staphylococcus aureus | 4 | 2019 | 438 | 0.390 |
Why?
| Oxides | 1 | 2012 | 41 | 0.390 |
Why?
| DNA, Mitochondrial | 1 | 2013 | 191 | 0.380 |
Why?
| Cholangiopancreatography, Endoscopic Retrograde | 2 | 2024 | 206 | 0.380 |
Why?
| Urothelium | 2 | 2022 | 37 | 0.380 |
Why?
| Genes, BRCA1 | 1 | 2011 | 32 | 0.380 |
Why?
| Reactive Oxygen Species | 2 | 2019 | 596 | 0.370 |
Why?
| Tuberculosis, Pulmonary | 2 | 2025 | 135 | 0.370 |
Why?
| Apoptosis | 5 | 2025 | 2503 | 0.370 |
Why?
| Particle Size | 2 | 2010 | 355 | 0.370 |
Why?
| HIV Infections | 3 | 2022 | 2720 | 0.370 |
Why?
| Iron | 2 | 2016 | 288 | 0.370 |
Why?
| Aziridines | 1 | 2011 | 5 | 0.360 |
Why?
| Aza Compounds | 1 | 2011 | 13 | 0.360 |
Why?
| Epigenomics | 1 | 2011 | 110 | 0.360 |
Why?
| Magnetic Resonance Imaging | 5 | 2018 | 3408 | 0.350 |
Why?
| Membrane Proteins | 3 | 2022 | 1119 | 0.350 |
Why?
| Gene Silencing | 1 | 2011 | 190 | 0.350 |
Why?
| Carbohydrates | 1 | 2011 | 64 | 0.350 |
Why?
| Proteomics | 2 | 2015 | 1062 | 0.350 |
Why?
| Breast Neoplasms | 3 | 2011 | 2142 | 0.340 |
Why?
| Enzyme Inhibitors | 4 | 2019 | 827 | 0.340 |
Why?
| Monocytes | 2 | 2016 | 551 | 0.340 |
Why?
| Thorium | 1 | 2009 | 1 | 0.330 |
Why?
| MicroRNAs | 1 | 2016 | 678 | 0.330 |
Why?
| Disease Models, Animal | 10 | 2025 | 4063 | 0.310 |
Why?
| Hypertrophy, Left Ventricular | 1 | 2010 | 126 | 0.310 |
Why?
| Mice | 15 | 2025 | 16937 | 0.300 |
Why?
| Death, Sudden, Cardiac | 1 | 2010 | 179 | 0.300 |
Why?
| Population Surveillance | 1 | 2011 | 439 | 0.300 |
Why?
| Microbial Viability | 2 | 2019 | 84 | 0.290 |
Why?
| Models, Chemical | 1 | 2009 | 265 | 0.290 |
Why?
| Immunity, Innate | 3 | 2023 | 804 | 0.280 |
Why?
| Bacterial Load | 2 | 2017 | 66 | 0.280 |
Why?
| Young Adult | 5 | 2024 | 12426 | 0.280 |
Why?
| Neoplasms | 3 | 2023 | 2470 | 0.280 |
Why?
| Diabetes Mellitus, Type 2 | 2 | 2024 | 2440 | 0.270 |
Why?
| Sports | 1 | 2010 | 225 | 0.270 |
Why?
| Organoids | 2 | 2018 | 104 | 0.270 |
Why?
| Gastrointestinal Microbiome | 2 | 2025 | 641 | 0.270 |
Why?
| Plant Diseases | 2 | 2024 | 39 | 0.270 |
Why?
| Microbial Sensitivity Tests | 3 | 2017 | 352 | 0.270 |
Why?
| Dysbiosis | 2 | 2025 | 169 | 0.250 |
Why?
| Adult | 10 | 2024 | 35572 | 0.250 |
Why?
| Dogs | 3 | 2024 | 381 | 0.240 |
Why?
| Nanoparticles | 1 | 2009 | 374 | 0.240 |
Why?
| Urbanization | 1 | 2025 | 27 | 0.240 |
Why?
| Trichoderma | 1 | 2024 | 27 | 0.230 |
Why?
| Female | 19 | 2025 | 68770 | 0.230 |
Why?
| Cell Line, Tumor | 4 | 2024 | 3215 | 0.230 |
Why?
| Recurrence | 2 | 2018 | 1007 | 0.230 |
Why?
| Aniline Compounds | 1 | 2025 | 98 | 0.230 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2021 | 3628 | 0.230 |
Why?
| Environmental Monitoring | 2 | 2023 | 318 | 0.230 |
Why?
| Extreme Heat | 1 | 2024 | 5 | 0.220 |
Why?
| Quantitative Structure-Activity Relationship | 1 | 2024 | 14 | 0.220 |
Why?
| Moringa oleifera | 1 | 2023 | 3 | 0.220 |
Why?
| Prospective Studies | 3 | 2024 | 7131 | 0.220 |
Why?
| Middle Aged | 9 | 2024 | 31150 | 0.220 |
Why?
| Glutamine | 1 | 2024 | 99 | 0.220 |
Why?
| Solid Waste | 1 | 2023 | 2 | 0.220 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2025 | 232 | 0.220 |
Why?
| Cold Temperature | 1 | 2025 | 155 | 0.220 |
Why?
| Drug Repositioning | 3 | 2019 | 25 | 0.210 |
Why?
| Cognition Disorders | 2 | 2018 | 504 | 0.210 |
Why?
| Magnetic Resonance Spectroscopy | 5 | 2012 | 539 | 0.210 |
Why?
| Cholecystectomy | 1 | 2023 | 59 | 0.210 |
Why?
| Pancreatitis | 1 | 2024 | 129 | 0.210 |
Why?
| Aging | 2 | 2018 | 1776 | 0.210 |
Why?
| Cities | 1 | 2023 | 105 | 0.210 |
Why?
| Spectroscopy, Mossbauer | 2 | 2013 | 2 | 0.210 |
Why?
| Heat Stress Disorders | 1 | 2024 | 69 | 0.200 |
Why?
| Tumor Microenvironment | 2 | 2024 | 634 | 0.200 |
Why?
| India | 3 | 2013 | 170 | 0.200 |
Why?
| Powders | 3 | 2012 | 43 | 0.200 |
Why?
| Pancreas | 2 | 2024 | 306 | 0.200 |
Why?
| Climate Change | 1 | 2025 | 165 | 0.200 |
Why?
| Ligands | 4 | 2012 | 622 | 0.200 |
Why?
| Electrons | 3 | 2012 | 79 | 0.200 |
Why?
| Chromatography, Liquid | 2 | 2015 | 423 | 0.200 |
Why?
| Kinetics | 4 | 2023 | 1642 | 0.200 |
Why?
| Cardiovascular System | 1 | 2024 | 137 | 0.200 |
Why?
| Soil Microbiology | 1 | 2024 | 207 | 0.190 |
Why?
| Pathogen-Associated Molecular Pattern Molecules | 1 | 2022 | 7 | 0.190 |
Why?
| Ketones | 2 | 2012 | 47 | 0.190 |
Why?
| Vero Cells | 2 | 2021 | 65 | 0.190 |
Why?
| Pacinian Corpuscles | 1 | 2021 | 1 | 0.190 |
Why?
| Male | 12 | 2024 | 63674 | 0.190 |
Why?
| Caenorhabditis elegans Proteins | 1 | 2024 | 193 | 0.190 |
Why?
| Adolescent | 6 | 2022 | 20391 | 0.190 |
Why?
| Nerve Fibers | 1 | 2022 | 89 | 0.180 |
Why?
| Receptor, trkB | 1 | 2021 | 30 | 0.180 |
Why?
| Acetamides | 1 | 2021 | 36 | 0.180 |
Why?
| Sulfonamides | 1 | 2025 | 496 | 0.180 |
Why?
| Mass Spectrometry | 3 | 2014 | 716 | 0.180 |
Why?
| Deficiency Diseases | 1 | 2020 | 10 | 0.180 |
Why?
| Retinal Ganglion Cells | 1 | 2022 | 97 | 0.180 |
Why?
| Iodine Radioisotopes | 1 | 2021 | 143 | 0.180 |
Why?
| Permeability | 1 | 2021 | 157 | 0.180 |
Why?
| Diverticulum, Esophageal | 1 | 2020 | 3 | 0.180 |
Why?
| Water Pollutants, Chemical | 1 | 2023 | 205 | 0.170 |
Why?
| Mice, Inbred BALB C | 3 | 2019 | 1245 | 0.170 |
Why?
| Myeloid Cells | 1 | 2022 | 143 | 0.170 |
Why?
| Pyrimidines | 2 | 2021 | 459 | 0.170 |
Why?
| Radiation Dosage | 1 | 2021 | 153 | 0.170 |
Why?
| History, 21st Century | 1 | 2021 | 183 | 0.170 |
Why?
| Esophageal Motility Disorders | 1 | 2020 | 26 | 0.170 |
Why?
| Tomography, Optical Coherence | 1 | 2022 | 187 | 0.170 |
Why?
| Staphylococcal Infections | 4 | 2019 | 393 | 0.170 |
Why?
| CD4 Antigens | 2 | 2017 | 138 | 0.170 |
Why?
| Antibodies, Neutralizing | 1 | 2022 | 265 | 0.170 |
Why?
| History, 20th Century | 1 | 2021 | 291 | 0.170 |
Why?
| Drug Discovery | 2 | 2018 | 131 | 0.170 |
Why?
| Cell Line | 2 | 2016 | 2781 | 0.170 |
Why?
| Drug Synergism | 2 | 2017 | 371 | 0.170 |
Why?
| Rats | 4 | 2022 | 5499 | 0.160 |
Why?
| Diarylquinolines | 1 | 2019 | 12 | 0.160 |
Why?
| Whole Body Imaging | 1 | 2019 | 20 | 0.160 |
Why?
| Caspases | 1 | 2020 | 245 | 0.160 |
Why?
| Genome, Bacterial | 1 | 2020 | 134 | 0.160 |
Why?
| Granulosa Cells | 1 | 2019 | 32 | 0.160 |
Why?
| Pyruvates | 1 | 2019 | 24 | 0.160 |
Why?
| Spectroscopy, Fourier Transform Infrared | 2 | 2023 | 82 | 0.160 |
Why?
| Toll-Like Receptors | 1 | 2020 | 179 | 0.160 |
Why?
| Glucose Tolerance Test | 1 | 2020 | 356 | 0.160 |
Why?
| Vitamin D Deficiency | 1 | 2020 | 176 | 0.150 |
Why?
| Fasting | 1 | 2020 | 267 | 0.150 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2019 | 182 | 0.150 |
Why?
| Oocytes | 1 | 2019 | 176 | 0.150 |
Why?
| Antineoplastic Agents | 2 | 2021 | 2061 | 0.150 |
Why?
| Thienamycins | 1 | 2017 | 5 | 0.150 |
Why?
| Botrytis | 1 | 2017 | 2 | 0.140 |
Why?
| Cicer | 1 | 2017 | 2 | 0.140 |
Why?
| Protein Processing, Post-Translational | 1 | 2020 | 455 | 0.140 |
Why?
| Mycobacterium marinum | 1 | 2017 | 3 | 0.140 |
Why?
| Mycobacterium leprae | 1 | 2017 | 8 | 0.140 |
Why?
| Gene Expression | 2 | 2020 | 1472 | 0.140 |
Why?
| Amikacin | 1 | 2017 | 23 | 0.140 |
Why?
| Ethambutol | 1 | 2017 | 25 | 0.140 |
Why?
| Basidiomycota | 1 | 2017 | 28 | 0.140 |
Why?
| Gene Expression Regulation | 2 | 2018 | 2548 | 0.140 |
Why?
| Obesity | 1 | 2011 | 2882 | 0.140 |
Why?
| Leprosy | 1 | 2017 | 22 | 0.140 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2018 | 119 | 0.140 |
Why?
| Betacoronavirus | 1 | 2020 | 249 | 0.140 |
Why?
| Blood Glucose | 2 | 2020 | 2097 | 0.140 |
Why?
| Thymocytes | 1 | 2017 | 33 | 0.140 |
Why?
| Ruthenium | 2 | 2014 | 34 | 0.140 |
Why?
| Carcinoma, Transitional Cell | 1 | 2017 | 60 | 0.140 |
Why?
| HIV | 1 | 2018 | 226 | 0.140 |
Why?
| Brain Edema | 1 | 2017 | 60 | 0.140 |
Why?
| Immunotherapy | 1 | 2021 | 592 | 0.140 |
Why?
| Immune Evasion | 1 | 2017 | 56 | 0.140 |
Why?
| Immunization | 1 | 2019 | 411 | 0.140 |
Why?
| Amino Acids | 1 | 2020 | 485 | 0.140 |
Why?
| Disease | 1 | 2018 | 95 | 0.140 |
Why?
| Forkhead Transcription Factors | 1 | 2018 | 185 | 0.140 |
Why?
| Demyelinating Diseases | 1 | 2017 | 84 | 0.140 |
Why?
| Neutropenia | 1 | 2017 | 136 | 0.140 |
Why?
| Small Molecule Libraries | 1 | 2017 | 86 | 0.130 |
Why?
| Learning | 1 | 2021 | 402 | 0.130 |
Why?
| Chloride Channel Agonists | 1 | 2017 | 77 | 0.130 |
Why?
| Beclin-1 | 1 | 2016 | 11 | 0.130 |
Why?
| Brain Mapping | 2 | 2018 | 574 | 0.130 |
Why?
| Arsenic | 1 | 2017 | 66 | 0.130 |
Why?
| Prostatic Neoplasms | 1 | 2024 | 1016 | 0.130 |
Why?
| Ubiquitin-Conjugating Enzymes | 1 | 2016 | 13 | 0.130 |
Why?
| Aged | 4 | 2024 | 22099 | 0.130 |
Why?
| Drug Combinations | 1 | 2017 | 330 | 0.130 |
Why?
| NF-E2-Related Factor 2 | 1 | 2017 | 79 | 0.130 |
Why?
| Autophagy-Related Proteins | 1 | 2016 | 42 | 0.130 |
Why?
| Influenza, Human | 1 | 2022 | 601 | 0.130 |
Why?
| Ions | 1 | 2016 | 66 | 0.130 |
Why?
| Signal Transduction | 4 | 2021 | 4925 | 0.130 |
Why?
| Tandem Mass Spectrometry | 2 | 2020 | 524 | 0.130 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2022 | 857 | 0.120 |
Why?
| Optical Imaging | 1 | 2016 | 56 | 0.120 |
Why?
| Oxidative Stress | 3 | 2019 | 1269 | 0.120 |
Why?
| Parasites | 1 | 2016 | 44 | 0.120 |
Why?
| Neoplasm Recurrence, Local | 1 | 2021 | 964 | 0.120 |
Why?
| Quinolones | 1 | 2017 | 126 | 0.120 |
Why?
| Treatment Outcome | 4 | 2024 | 10226 | 0.120 |
Why?
| Urinary Bladder | 1 | 2017 | 175 | 0.120 |
Why?
| Up-Regulation | 2 | 2016 | 840 | 0.120 |
Why?
| Aminophenols | 1 | 2017 | 144 | 0.120 |
Why?
| Oryza | 2 | 2014 | 31 | 0.120 |
Why?
| Kaplan-Meier Estimate | 1 | 2017 | 857 | 0.120 |
Why?
| Neuroimaging | 1 | 2017 | 279 | 0.120 |
Why?
| Electroencephalography | 1 | 2017 | 403 | 0.120 |
Why?
| T-Lymphocyte Subsets | 1 | 2017 | 412 | 0.120 |
Why?
| Glycoside Hydrolase Inhibitors | 1 | 2014 | 3 | 0.120 |
Why?
| Cluster Analysis | 1 | 2016 | 482 | 0.120 |
Why?
| alpha-Glucosidases | 1 | 2014 | 12 | 0.120 |
Why?
| Case-Control Studies | 2 | 2020 | 3381 | 0.120 |
Why?
| Logistic Models | 2 | 2017 | 1988 | 0.120 |
Why?
| Pyridines | 2 | 2018 | 478 | 0.120 |
Why?
| Spectrometry, Fluorescence | 2 | 2014 | 171 | 0.120 |
Why?
| Palladium | 1 | 2014 | 14 | 0.120 |
Why?
| Immunoblotting | 1 | 2015 | 305 | 0.110 |
Why?
| T-Lymphocytes, Regulatory | 1 | 2017 | 375 | 0.110 |
Why?
| Ornithine Decarboxylase | 1 | 2014 | 10 | 0.110 |
Why?
| Fluorescent Dyes | 1 | 2016 | 317 | 0.110 |
Why?
| Spermidine | 1 | 2014 | 18 | 0.110 |
Why?
| Subcellular Fractions | 1 | 2014 | 81 | 0.110 |
Why?
| Polyamines | 1 | 2014 | 39 | 0.110 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 331 | 0.110 |
Why?
| Antioxidants | 1 | 2017 | 559 | 0.110 |
Why?
| Body Mass Index | 2 | 2013 | 2273 | 0.110 |
Why?
| Free Radicals | 1 | 2014 | 106 | 0.110 |
Why?
| Agriculture | 2 | 2024 | 93 | 0.110 |
Why?
| Microscopy, Electron, Transmission | 2 | 2011 | 146 | 0.110 |
Why?
| GTP Phosphohydrolases | 1 | 2014 | 85 | 0.110 |
Why?
| Pancreatic Neoplasms | 1 | 2021 | 882 | 0.110 |
Why?
| Molecular Structure | 2 | 2014 | 482 | 0.110 |
Why?
| Powder Diffraction | 1 | 2013 | 3 | 0.110 |
Why?
| Vaccination | 1 | 2022 | 1348 | 0.110 |
Why?
| Postprandial Period | 1 | 2013 | 104 | 0.100 |
Why?
| Magnetic Phenomena | 1 | 2012 | 10 | 0.100 |
Why?
| Predictive Value of Tests | 1 | 2018 | 1952 | 0.100 |
Why?
| Protein Folding | 1 | 2014 | 266 | 0.100 |
Why?
| Mice, Inbred C57BL | 4 | 2025 | 5440 | 0.100 |
Why?
| Vanadates | 1 | 2012 | 14 | 0.100 |
Why?
| Mental Disorders | 1 | 2020 | 1030 | 0.100 |
Why?
| Glutathione | 1 | 2014 | 348 | 0.100 |
Why?
| Age Factors | 1 | 2019 | 3144 | 0.100 |
Why?
| Molecular Weight | 1 | 2012 | 332 | 0.100 |
Why?
| Drug Resistance, Neoplasm | 1 | 2017 | 759 | 0.100 |
Why?
| Topoisomerase II Inhibitors | 1 | 2011 | 24 | 0.090 |
Why?
| Pandemics | 1 | 2020 | 1486 | 0.090 |
Why?
| Child | 5 | 2018 | 20882 | 0.090 |
Why?
| Lung | 5 | 2025 | 3931 | 0.090 |
Why?
| Antimony | 1 | 2011 | 5 | 0.090 |
Why?
| Genome, Plant | 1 | 2011 | 50 | 0.090 |
Why?
| Droughts | 1 | 2011 | 42 | 0.090 |
Why?
| Amides | 1 | 2011 | 91 | 0.090 |
Why?
| Gallbladder Neoplasms | 1 | 2011 | 20 | 0.090 |
Why?
| DNA Repair | 2 | 2011 | 207 | 0.090 |
Why?
| Protozoan Proteins | 1 | 2011 | 75 | 0.090 |
Why?
| Stereoisomerism | 1 | 2011 | 99 | 0.090 |
Why?
| Cognition | 1 | 2018 | 1122 | 0.090 |
Why?
| Cross-Sectional Studies | 1 | 2022 | 5066 | 0.090 |
Why?
| Pentanones | 1 | 2010 | 3 | 0.090 |
Why?
| Pyrroles | 1 | 2011 | 202 | 0.090 |
Why?
| Alloys | 1 | 2010 | 33 | 0.080 |
Why?
| Streptococcus pneumoniae | 1 | 2011 | 159 | 0.080 |
Why?
| Polymers | 1 | 2014 | 479 | 0.080 |
Why?
| Tuberculosis, Spinal | 1 | 2009 | 7 | 0.080 |
Why?
| Insulin | 1 | 2020 | 2326 | 0.080 |
Why?
| Epidural Abscess | 1 | 2009 | 6 | 0.080 |
Why?
| Magnetics | 1 | 2009 | 44 | 0.080 |
Why?
| Quantitative Trait Loci | 1 | 2011 | 355 | 0.080 |
Why?
| Proto-Oncogenes | 1 | 2009 | 29 | 0.080 |
Why?
| Temperature | 1 | 2012 | 636 | 0.080 |
Why?
| DNA Methylation | 2 | 2011 | 607 | 0.080 |
Why?
| Prognosis | 1 | 2017 | 3794 | 0.080 |
Why?
| Genes, Tumor Suppressor | 1 | 2009 | 86 | 0.080 |
Why?
| Acetates | 1 | 2009 | 100 | 0.080 |
Why?
| Biomarkers | 3 | 2017 | 3973 | 0.080 |
Why?
| Peptides | 1 | 2014 | 925 | 0.070 |
Why?
| Follow-Up Studies | 1 | 2017 | 4896 | 0.070 |
Why?
| Kidney Failure, Chronic | 1 | 2013 | 547 | 0.070 |
Why?
| Cause of Death | 1 | 2010 | 393 | 0.070 |
Why?
| Copper | 1 | 2008 | 109 | 0.070 |
Why?
| Promoter Regions, Genetic | 1 | 2011 | 1207 | 0.070 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2011 | 511 | 0.070 |
Why?
| Time Factors | 1 | 2017 | 6556 | 0.070 |
Why?
| Adsorption | 2 | 2023 | 139 | 0.070 |
Why?
| RNA | 2 | 2023 | 883 | 0.060 |
Why?
| Biological Control Agents | 1 | 2024 | 3 | 0.060 |
Why?
| Mutation | 2 | 2013 | 3717 | 0.060 |
Why?
| Pest Control, Biological | 1 | 2024 | 9 | 0.060 |
Why?
| Salmonella typhi | 1 | 2005 | 13 | 0.060 |
Why?
| Typhoid Fever | 1 | 2005 | 10 | 0.060 |
Why?
| Zinc | 1 | 2008 | 294 | 0.060 |
Why?
| Prevalence | 1 | 2011 | 2564 | 0.060 |
Why?
| Risk Factors | 2 | 2024 | 9763 | 0.050 |
Why?
| Nucleotidyltransferases | 1 | 2023 | 27 | 0.050 |
Why?
| Interleukin-1 | 1 | 2008 | 958 | 0.050 |
Why?
| Phosphoric Diester Hydrolases | 1 | 2023 | 46 | 0.050 |
Why?
| Chickens | 1 | 2024 | 188 | 0.050 |
Why?
| Inhibitory Concentration 50 | 2 | 2014 | 86 | 0.050 |
Why?
| Microchemistry | 1 | 2003 | 20 | 0.050 |
Why?
| Neuropsychological Tests | 2 | 2018 | 1015 | 0.050 |
Why?
| Models, Biological | 1 | 2010 | 1722 | 0.050 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 1356 | 0.050 |
Why?
| Metagenomics | 1 | 2024 | 156 | 0.050 |
Why?
| Severity of Illness Index | 1 | 2011 | 2742 | 0.050 |
Why?
| Soil | 1 | 2024 | 228 | 0.050 |
Why?
| Animals, Wild | 1 | 2022 | 52 | 0.050 |
Why?
| Neutralization Tests | 1 | 2022 | 73 | 0.050 |
Why?
| Plants | 1 | 2024 | 217 | 0.050 |
Why?
| Nitric Oxide | 1 | 2008 | 902 | 0.050 |
Why?
| Administration, Intranasal | 1 | 2022 | 84 | 0.050 |
Why?
| Hydrogen-Ion Concentration | 1 | 2023 | 544 | 0.050 |
Why?
| Models, Animal | 1 | 2024 | 376 | 0.050 |
Why?
| Administration, Intravesical | 1 | 2021 | 15 | 0.050 |
Why?
| Cells, Cultured | 2 | 2020 | 4083 | 0.050 |
Why?
| Mammals | 1 | 2023 | 271 | 0.050 |
Why?
| Viral Envelope Proteins | 1 | 2022 | 81 | 0.050 |
Why?
| Polymerase Chain Reaction | 1 | 2005 | 1038 | 0.050 |
Why?
| Crystallography, X-Ray | 2 | 2014 | 436 | 0.050 |
Why?
| Reward | 1 | 2024 | 240 | 0.050 |
Why?
| Thermodynamics | 1 | 2023 | 408 | 0.050 |
Why?
| CRISPR-Cas Systems | 1 | 2022 | 109 | 0.050 |
Why?
| Hot Temperature | 1 | 2024 | 370 | 0.050 |
Why?
| Biosensing Techniques | 1 | 2003 | 120 | 0.050 |
Why?
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 108 | 0.050 |
Why?
| Feces | 1 | 2024 | 440 | 0.050 |
Why?
| Cricetinae | 1 | 2021 | 277 | 0.050 |
Why?
| Positron Emission Tomography Computed Tomography | 1 | 2021 | 85 | 0.040 |
Why?
| Base Composition | 1 | 2020 | 76 | 0.040 |
Why?
| Medical Illustration | 1 | 2020 | 9 | 0.040 |
Why?
| Caenorhabditis elegans | 1 | 2024 | 291 | 0.040 |
Why?
| Azides | 1 | 2020 | 46 | 0.040 |
Why?
| Brain-Derived Neurotrophic Factor | 1 | 2021 | 114 | 0.040 |
Why?
| Ubiquitination | 1 | 2020 | 98 | 0.040 |
Why?
| Water | 1 | 2023 | 448 | 0.040 |
Why?
| Skin Diseases, Parasitic | 1 | 2020 | 2 | 0.040 |
Why?
| Guinea Pigs | 1 | 2020 | 157 | 0.040 |
Why?
| Membrane Glycoproteins | 1 | 2022 | 474 | 0.040 |
Why?
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 211 | 0.040 |
Why?
| Autoradiography | 1 | 2019 | 73 | 0.040 |
Why?
| Plasticizers | 1 | 2019 | 14 | 0.040 |
Why?
| Computational Biology | 1 | 2024 | 599 | 0.040 |
Why?
| Diethylhexyl Phthalate | 1 | 2019 | 15 | 0.040 |
Why?
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2019 | 15 | 0.040 |
Why?
| Membrane Potential, Mitochondrial | 1 | 2019 | 68 | 0.040 |
Why?
| Transferrin | 1 | 2019 | 42 | 0.040 |
Why?
| Public Health | 1 | 2024 | 484 | 0.040 |
Why?
| DNA, Bacterial | 1 | 2020 | 324 | 0.040 |
Why?
| Pilot Projects | 1 | 2024 | 1587 | 0.040 |
Why?
| Administration, Intravenous | 1 | 2019 | 141 | 0.040 |
Why?
| Inflammation Mediators | 1 | 2021 | 505 | 0.040 |
Why?
| Antibodies, Viral | 1 | 2022 | 601 | 0.040 |
Why?
| Esophagus | 1 | 2020 | 248 | 0.040 |
Why?
| Methylnitrosourea | 1 | 2017 | 7 | 0.040 |
Why?
| Phenotype | 2 | 2020 | 3076 | 0.040 |
Why?
| Cell Physiological Phenomena | 1 | 2018 | 17 | 0.040 |
Why?
| Immunoglobulin G | 1 | 2022 | 847 | 0.040 |
Why?
| Plant Shoots | 1 | 2017 | 4 | 0.040 |
Why?
| Models, Molecular | 2 | 2014 | 1492 | 0.040 |
Why?
| Antibiosis | 1 | 2017 | 9 | 0.040 |
Why?
| Neuregulin-1 | 1 | 2018 | 46 | 0.040 |
Why?
| Core Binding Factor Alpha 3 Subunit | 1 | 2017 | 6 | 0.040 |
Why?
| NADH, NADPH Oxidoreductases | 1 | 2017 | 17 | 0.040 |
Why?
| Indoles | 1 | 2020 | 387 | 0.040 |
Why?
| Disease Resistance | 1 | 2017 | 31 | 0.040 |
Why?
| Depressive Disorder | 1 | 2020 | 366 | 0.040 |
Why?
| Anxiety Disorders | 1 | 2020 | 356 | 0.040 |
Why?
| Catalase | 1 | 2017 | 129 | 0.040 |
Why?
| Sequence Analysis, DNA | 1 | 2020 | 779 | 0.040 |
Why?
| Rats, Inbred F344 | 1 | 2017 | 257 | 0.030 |
Why?
| Neoplasms, Experimental | 1 | 2018 | 171 | 0.030 |
Why?
| Lymphocyte Count | 1 | 2017 | 148 | 0.030 |
Why?
| Primary Cell Culture | 1 | 2017 | 160 | 0.030 |
Why?
| Coculture Techniques | 1 | 2017 | 226 | 0.030 |
Why?
| Rifampin | 1 | 2017 | 85 | 0.030 |
Why?
| Cytoprotection | 1 | 2017 | 56 | 0.030 |
Why?
| Spheroids, Cellular | 1 | 2017 | 77 | 0.030 |
Why?
| Protein Binding | 2 | 2014 | 2121 | 0.030 |
Why?
| Phylogeny | 1 | 2020 | 852 | 0.030 |
Why?
| Longevity | 1 | 2018 | 151 | 0.030 |
Why?
| Antiviral Agents | 1 | 2022 | 712 | 0.030 |
Why?
| Protein Isoforms | 1 | 2018 | 391 | 0.030 |
Why?
| Aged, 80 and over | 1 | 2008 | 7084 | 0.030 |
Why?
| Diagnosis, Differential | 1 | 2020 | 1434 | 0.030 |
Why?
| Mercury | 1 | 2016 | 40 | 0.030 |
Why?
| Sulfur | 1 | 2016 | 51 | 0.030 |
Why?
| Cell Lineage | 1 | 2017 | 333 | 0.030 |
Why?
| Spleen | 1 | 2017 | 507 | 0.030 |
Why?
| Superoxide Dismutase | 1 | 2017 | 342 | 0.030 |
Why?
| Neural Pathways | 1 | 2017 | 302 | 0.030 |
Why?
| Imino Sugars | 1 | 2014 | 1 | 0.030 |
Why?
| Alkaloids | 1 | 2014 | 28 | 0.030 |
Why?
| Bacterial Proteins | 1 | 2020 | 835 | 0.030 |
Why?
| Spectrophotometry, Ultraviolet | 1 | 2014 | 84 | 0.030 |
Why?
| HeLa Cells | 1 | 2016 | 608 | 0.030 |
Why?
| Chemistry, Pharmaceutical | 1 | 2014 | 107 | 0.030 |
Why?
| Precision Medicine | 1 | 2018 | 387 | 0.030 |
Why?
| Optical Devices | 1 | 2014 | 13 | 0.030 |
Why?
| Molecular Conformation | 1 | 2014 | 144 | 0.030 |
Why?
| Siloxanes | 1 | 2014 | 6 | 0.030 |
Why?
| Tin Compounds | 1 | 2014 | 17 | 0.030 |
Why?
| Semiconductors | 1 | 2014 | 36 | 0.030 |
Why?
| Nerve Net | 1 | 2017 | 260 | 0.030 |
Why?
| Drug Design | 1 | 2014 | 156 | 0.030 |
Why?
| Imaging, Three-Dimensional | 1 | 2017 | 531 | 0.030 |
Why?
| Triazoles | 1 | 2014 | 152 | 0.030 |
Why?
| Fibroblasts | 1 | 2017 | 948 | 0.020 |
Why?
| DNA Gyrase | 1 | 2011 | 12 | 0.020 |
Why?
| Electron Spin Resonance Spectroscopy | 1 | 2012 | 91 | 0.020 |
Why?
| Crops, Agricultural | 1 | 2011 | 29 | 0.020 |
Why?
| Edible Grain | 1 | 2011 | 48 | 0.020 |
Why?
| Breeding | 1 | 2011 | 62 | 0.020 |
Why?
| Hydrolysis | 1 | 2011 | 186 | 0.020 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2017 | 1056 | 0.020 |
Why?
| Ribosomal Proteins | 1 | 2011 | 77 | 0.020 |
Why?
| Drug Resistance, Bacterial | 1 | 2011 | 176 | 0.020 |
Why?
| Oxidation-Reduction | 1 | 2014 | 1033 | 0.020 |
Why?
| Heat-Shock Proteins | 1 | 2011 | 136 | 0.020 |
Why?
| Chromosome Mapping | 1 | 2011 | 504 | 0.020 |
Why?
| Cell Differentiation | 1 | 2017 | 1902 | 0.020 |
Why?
| Tubulin | 1 | 2011 | 137 | 0.020 |
Why?
| Laminectomy | 1 | 2009 | 29 | 0.020 |
Why?
| Glycolysis | 1 | 2011 | 311 | 0.020 |
Why?
| Paraplegia | 1 | 2009 | 57 | 0.020 |
Why?
| Chromosomes, Human | 1 | 2009 | 41 | 0.020 |
Why?
| Transcription Factors | 1 | 2017 | 1651 | 0.020 |
Why?
| Loss of Heterozygosity | 1 | 2009 | 46 | 0.020 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2011 | 582 | 0.020 |
Why?
| Down-Regulation | 1 | 2011 | 636 | 0.020 |
Why?
| Carcinogens | 1 | 2009 | 110 | 0.020 |
Why?
| Cell Transformation, Neoplastic | 1 | 2011 | 328 | 0.020 |
Why?
| Binding Sites | 1 | 2011 | 1252 | 0.020 |
Why?
| Cell Cycle | 1 | 2011 | 592 | 0.020 |
Why?
| Genome, Human | 1 | 2009 | 393 | 0.020 |
Why?
| Blood Pressure | 1 | 2013 | 1735 | 0.020 |
Why?
| Disease Progression | 1 | 2013 | 2635 | 0.020 |
Why?
| Hypoglycemic Agents | 1 | 2014 | 1220 | 0.020 |
Why?
| Agglutination Tests | 1 | 2005 | 4 | 0.010 |
Why?
| Blood | 1 | 2005 | 104 | 0.010 |
Why?
| Culture Media | 1 | 2005 | 162 | 0.010 |
Why?
| Silicon | 1 | 2003 | 14 | 0.010 |
Why?
| Glucose Oxidase | 1 | 2003 | 26 | 0.010 |
Why?
| Child, Preschool | 2 | 2009 | 10518 | 0.010 |
Why?
| Enzymes, Immobilized | 1 | 2003 | 29 | 0.010 |
Why?
| Gold | 1 | 2003 | 119 | 0.010 |
Why?
| Surface Properties | 1 | 2003 | 399 | 0.010 |
Why?
| Equipment Design | 1 | 2003 | 513 | 0.010 |
Why?
| Stress, Mechanical | 1 | 2003 | 467 | 0.010 |
Why?
| Sensitivity and Specificity | 1 | 2005 | 1838 | 0.010 |
Why?
| Glucose | 1 | 2003 | 1003 | 0.010 |
Why?
| Infant | 1 | 2005 | 9025 | 0.010 |
Why?
|
|
Singh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|